Gene expression of aurora kinases in prostate cancer and nodular hyperplasia tissues

Medical Principles and Practice

Volumn 22, Issue 2, 2013, Pages 138-143

  Nna, Emmanuel ^a   Madukwe, Jonathan ^b   Egbujo, Ejike ^c   Obiorah, Chris ^d   Okolie, Charles ^c   Echejoh, Godwin ^c   Yahaya, Amina ^c   Adisa, James ^c   Uzoma, Ijeoma ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b NATIONAL HOSPITAL   (Nigeria)

^c UNIVERSITY OF JOS   (Nigeria)

^d UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Aurora kinase A; Aurora kinase B; Aurora kinase C; Aurora kinases; Gene expression; Prostate cancer

Indexed keywords

COMPLEMENTARY DNA; RNA; AURORA A KINASE; AURORA B KINASE; AURORA C KINASE; FORMALDEHYDE; MESSENGER RNA; PARAFFIN; RNA 18S; RNA 28S;

ARTICLE; AURORA A KINASE GENE; AURORA B KINASE GENE; AURORA C KINASE GENE; AURORA KINASE GENE; BENIGN NODULAR HYPERPLASIA; CONTROLLED STUDY; DNA EXTRACTION; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; ONCOGENE; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE SECTION; COMPARATIVE STUDY; DNA SYNTHESIS; PROSTATE TUMOR; RNA ANALYSIS;

CHI-SQUARE DISTRIBUTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84873734620     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000342679     Document Type: Article

References (14)

1. Marumoto T, Zhang D, Saya H: Aurora-A-A guardian of poles. Nat Rev Cancer 2005; 5: 42-50
2. Scharer CD, Laycock N, Osunkoya AO, Logani S, McDonald JF, Benigno BB, Moreno CS: Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. J Transl Med 2008; 6: 79
3. Lee EC, Frolov A, Li R, Ayala G, Greenberg NM: Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006; 66: 4996-5002
4. Chieffi P, Cozzolino L, Kisslinger A, Libertini S, Staibano S, Mansueto G, De Rosa G, Villacci A, Vitale M, Linardopoulos S, et al: Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 2006; 66: 326-333
5. Giet R, Glover DM: Drosophila Aurora B kinase is required for histone h3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis. J Cell Biol 2001; 152: 669-681
6. Seki A, Coppinger JA, Jang CY, Yates JR, Fang G: Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 2008; 320: 1655-1658
7. Qu Y, Zhang L, Mao M, Zhao F, Huang X, Yang C, Xiong Y, Mu D: Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer. Cancer Gene Ther 2008; 15: 517-525
8. Keen N, Taylor S: Aurora kinase inhibitors as anticancer agents. Nat Rev Cancer 2004; 4: 927-936
9. Nna E, Tothill IE, Ludeman L, Bailey T: Endogenous control genes in prostate cells: evaluation of gene expression using 'realtime' quantitative polymerase chain reaction. Med Princ Pract 2010; 19: 433-439
10. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 2002-2007
11. Katayama H, Sen S: Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta 2010; 1799: 829-839
12. Haqq C, Li R, Khodabakhsh D, Frolov A, Ginzinger D, Thompson T, Wheeler T, Carroll P, Ayala G: Ethnic and racial differences in prostate stromal estrogen receptor - . Prostate 2005; 65: 101-109
13. Libertini S, Abagnale A, Passaro C, Botta G, Portella G: Aurora A and B kinases-Targets of novel anticancer drugs. Recent Pat Anticancer Drug Discov 2010; 5: 219-241
14. Al-Mulla F, Bitar MS, Taqi Z, Rath O, Kolch W: RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility. Mol Biosyst 2011; 7: 928-941.